Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 7—July 2018

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015

Catarina Silva-Costa, Maria João Brito, Marcos D. Pinho, Ana Friães, Sandra I. Aguiar1, M. RamirezComments to Author , Jose Melo-Cristino, on behalf of the Portuguese Group for the Study of Streptococcal Infectionsthe Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society
Author affiliations: Instituto de Microbiologia, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisbon, Lisbon, Portugal (C. Silva-Costa, M.D. Pinho, A. Friães, S.I. Aguiar, M. Ramirez, J. Melo-Cristino); Centro Hospitalar de Lisboa Central, Lisbon (M.J. Brito)

Main Article

Table 1

PCV immunization schemes according to guidelines from the Vaccines Committee of the Pediatric Infectious Diseases Society and Portuguese Pediatric Society*

Start of vaccination scheme
Primary immunization course
Booster vaccination
2–6 mo 3 doses, at 2, 4, and 6 mo 12–15 mo
7–11 mo 2 doses Booster dose at 12 mo†
12–23 mo 2 doses‡ NA
24–59 mo
Risk group only: 2 doses
PCV13 2–6 mo 2 or 3 doses§ 11–15 mo¶
7–11 mo 2 doses§ 11–15 mo¶
12–23 mo 2 doses‡ NA
>24 mo 1 dose NA

*NA, not applicable; PCV, pneumococcal conjugate vaccine; PCV7, 7-valent PCV; PCV13, 13-valent PCV.
†8 weeks after the second dose.
>8 weeks apart.
§Minimum interval between doses 4 weeks.
¶Minimum interval from last dose 8 weeks.

Main Article

1Current affiliation: Centro de Investigação Interdisciplinar em Sanidade Animal (CIISA), Faculdade de Medicina Veterinária, Universidade de Lisboa, Lisboa, Portugal.

2Members of the group are listed at the end of this article.

Page created: June 18, 2018
Page updated: June 18, 2018
Page reviewed: June 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.